Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zyprexa 10mg tablets
040201060BBACAC
|
Zyprexa | Olanzapine | Central Nervous System | 721 |
|
Paraldehyde 50% in Olive oil rectal solution
0408020Q0AAAJAJ
|
Paraldehyde | Paraldehyde | Central Nervous System | 720 |
|
Prochlorperazine 5mg/5ml oral solution
0406000U0AAAAAA
|
Prochlpzine mesilate | Prochlorperazine mesilate | Central Nervous System | 717 |
|
Desitrend 500mg granules sachets
0408010A0BDABAL
|
Desitrend | Levetiracetam | Central Nervous System | 711 |
|
Morphine 100mg modified-release tablets
0407020Q0AAAHAH
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 711 |
|
Betahistine 24mg tablets
0406000B0AAAHAH
|
Betahistine hydrochloride | Betahistine hydrochloride | Central Nervous System | 709 |
|
Seroquel 200mg tablets
0402010ABBBADAD
|
Seroquel | Quetiapine | Central Nervous System | 709 |
|
Zebinix 800mg tablets
0408010AIBBAAAA
|
Zebinix | Eslicarbazepine acetate | Central Nervous System | 704 |
|
Spiroco XL 8mg tablets
0409010H0BDACAM
|
Spiroco XL | Ropinirole hydrochloride | Central Nervous System | 702 |
|
Mintreleq XL 300mg tablets
0402010ABBJADAX
|
Mintreleq XL | Quetiapine | Central Nervous System | 697 |
|
Olanzapine 5mg oral lyophilisates sugar free
040201060AAAEAE
|
Olanzapine | Olanzapine | Central Nervous System | 696 |
|
Levomepromazine 6.25mg tablets
0402010K0AAAWAW
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | 693 |
|
Sertraline 100mg/5ml oral suspension
0403030Q0AAARAR
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 693 |
|
Spiroco XL 2mg tablets
0409010H0BDAAAK
|
Spiroco XL | Ropinirole hydrochloride | Central Nervous System | 683 |
|
Paracetamol 250mg orodispersible tablets sugar free
0407010H0AADCDC
|
Paracetamol | Paracetamol | Central Nervous System | 678 |
|
Trimipramine 10mg tablets
0403010Y0AAABAB
|
Trimipramine maleate | Trimipramine maleate | Central Nervous System | 678 |
|
Mirapexin 0.088mg tablets
0409010W0BBACAC
|
Mirapexin | Pramipexole | Central Nervous System | 673 |
|
Sinemet 10mg/100mg tablets
0409010N0BBAAAA
|
Sinemet | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | 673 |
|
Palexia SR 50mg tablets
0407020AGBBACAC
|
Palexia | Tapentadol | Central Nervous System | 672 |
|
Brivaracetam 10mg tablets
0408010ALAAAAAA
|
Brivaracetam | Brivaracetam | Central Nervous System | 670 |
|
Ropinirole 5mg tablets
0409010H0AAADAD
|
Ropinirole hydrochloride | Ropinirole hydrochloride | Central Nervous System | 670 |
|
Nicorette Freshmint 2mg medicated chewing gum
0410020B0BBAPBA
|
Nicorette | Nicotine | Central Nervous System | 669 |
|
Tapentadol 75mg tablets
0407020AGAAABAB
|
Tapentadol | Tapentadol | Central Nervous System | 668 |
|
Matoride XL 18mg tablets
0404000M0BHACAM
|
Matoride | Methylphenidate hydrochloride | Central Nervous System | 667 |
|
Imigran Subject 6mg/0.5ml inj syringe refill pack
0407041T0BBAEAE
|
Imigran | Sumatriptan succinate | Central Nervous System | 666 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.